Quarterly report pursuant to Section 13 or 15(d)

Organization and Significant Accounting Policies (Details Narrative)

v2.4.0.8
Organization and Significant Accounting Policies (Details Narrative) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Organization And Significant Accounting Policies Details Narrative            
Loss from operations $ (1,219) $ (1,005) $ (4,139) $ (3,095)    
Accumulated deficit 10,500   10,500      
Net loss (2,549) (1,005) 1,808 (3,093)    
Cash used in operating activities     (4,257) (2,878)    
Cash and cash equivalents 3,006 1,843 3,006 1,843 1,034 4,717
Shares owned 510,000   510,000      
Shares released 90,000   90,000      
Recognized loss on return of shares 584   584      
Portion of shares in escrow 260,000   600,000      
Musclepharm repurchase of shares $ 2,500   $ 2,500